Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Antithrombin III Deficiency
- Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass
- Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery
- Antithrombin III in Infectious Disease Caused by COVID-19
- Response of Continuous Recombinant Antithrombin Infusion in Postcardiotomy ECMO Patients
- Atenativ Effect on Uterine Blood Flow and Preeclampsia
- Anti-thrombin III (ATIII) vs Placebo in Children (<7mo) Undergoing Open Congenital Cardiac Surgery
- Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery
- A Study of KW-3357 in Congenital Antithrombin Deficiency
- Use of Antithrombin in Cardiac Surgery With Cardiopulmonary Bypass
- Safety, Pharmacokinetics and Efficacy of an AT-III Concentrate.